( MENAFN - Investor Brand Network) New research by scientists from the Oregon health & Science University and Johns Hopkins Kimmel Cancer Center has found a new approach that can make tumors resistant ...
Therefore, incorporating cosmetic medicine as a part of employee benefit programs is attracting attention as an initiative ...
Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer ...
The $1.2 billion company has some of the biggest podcast bros and athletes touting its praises. Is the greens powder the ...
Artificial intelligence is making impressive strides in its ability to read medical images. In a recent test in Britain's ...
A 35-year-old veterinarian took his own life after enduring significant stress in both his personal and professional life. Dr ...
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...
Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8IM8 launch marks a bold entry into the $187 ...
According to Ryan, these reforms resulting from the settlement give the University the option to share a portion of their ...
When it comes to carrying out a successful rebrand or transformation, these celebrities offered up a masterclass ...
An international team of researchers have developed a 'promising' new drug which could help combat the spread of treatment-resistant malaria. The breakthrough development is the first to adapt an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback